Pharmaceutical Quality Symposium 2023 - Day 2

Pharmaceutical Quality Symposium 2023 - Day 1

Roundtable on PMTA Submissions for ENDS Products

FDA Expert Panel on Testosterone Replacement Therapy for Men

FDA Grand Rounds - Statistical Considerations for Drug Development in Rare Disease

FDA's Public Meeting on Food Allergen Thresholds - 02/18/2026

FDA Grand Rounds - Adopting Large Language Models for Regulatory Review

Medical Device Quality Management System Regulation Design and Development

FDA Grand Rounds - Antibody Glycosylation Insights for High Quality Biotherapeutics

FDA Grand Rounds - Postmarket Regulation of Cosmetic Products: The Who, What, When, Why, and How

January 22, 2026: Tobacco Products Scientific Advisory Committee Meeting

FDA Drug Manufacturing Inspections - REdI 2020

FDA Grand Rounds - Advancing Real World Evidence in FDA Regulatory Decision Making

FDA Grand Rounds - Anti biofilm Technologies for Enhancing the Safety of Medical Device Surfaces

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

Public Meeting: Reauthorization of the Biosimilar User Fee Act

FDA-USP-AAM | D1S2 – Strengthening Your Compendial Strategy

FDA Grand Rounds - Forensic Proteomics Applied to FDA Regulated Products

API Facility Inspections

FDA-USP-AAM | D1S1 – FDA's Participation in USP-NF Revision Process – Challenges and Solutions

FDA-USP-AAM | D1S3 - Industry’s Engagement in USP’s Standards-Setting Process